Imunon Eulerpool Vijesti

Imunon Aktie News

Imunon prate mnogi novinari i investitori širom svijeta. Najnovije Imunon vijesti prikupljamo ovdje.

• 10. prosinca ·

  Yahoo
  IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
• 11. studenoga ·

  Yahoo
  IMNN: Meeting with FDA in Preparation for Phase 3 Ovarian Cancer Trial
• 8. studenoga ·

  Yahoo
  Imunon Inc (IMNN) Q3 2024 Earnings Call Highlights: Promising Clinical Advances Amid Financial ...
• 7. studenoga ·

  Yahoo
  IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting
• 30. listopada ·

  TipRanks
  Imunon to present Phase 2 data of IMNN-001
• 8. listopada ·

  Yahoo
  Imunon reports inducement grant under NASDAQ listing rule
• 7. listopada ·

  Yahoo
  IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
• 7. listopada ·

  TipRanks
  Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team
• 9. rujna ·

  Yahoo
  UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
• 9. rujna ·

  Yahoo
  IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management